This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letter to the Editor

Possible Impact of Dropout in a Study of High-Dose Olanzapine and Prolactin Levels

Chittaranjan Andrade, MD

Published: August 16, 2004

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Prolactin elevation as a consequence of antipsychotic drug therapy may result in decreased sexual desire, difficulties in sexual performance, and gynecomastia in men and in amenorrhea, infertility, breast engorgement, and lactation in women.1 Karagianis and Baksh2 studied 24 patients to determine whether high-dose (20-40 mg/day) olanzapine was associated with prolactin elevation. They found that there was no correlation between dose of olanzapine and prolactin level, that the highest elevation of prolactin was 20 ng/mL, and that only 21% of patients had (mildly) elevated prolactin levels.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 65

Quick Links: